SCYX Stock — Scynexis Inc: Metrics

Market overview

2 metrics

Share price

$5.35

Market cap

$51.44M

Price action

19 metrics

Price change (1W)

-7.9%

Price change (30D)

-3.3%

Price change (3M)

+11.8%

Price change (6M)

—

Price change (YTD)

—

Price change (1Y)

—

Trailing year

Price change (5Y)

—

52-week high

—

52-week low

—

Change from 52-week high

—

Change from 52-week low

—

Annualized volatility

89.1%

Beta

—

RSI (14D)

54.2

Price vs SMA 50

+12.1%

Price vs SMA 200

—

Avg volume (3M)

136,635

Relative volume

0.3

Average dollar volume

$644,321

Company

3 metrics

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Shares outstanding

9.95M

Valuation

12 metrics

P / E (TTM)

—

Trailing earnings

PEG ratio

—

EV / revenue

—

EV / EBITDA

—

EV / EBIT

—

P / sales

2.7×

reciprocal yield 37.4%

P / book

0.8

reciprocal yield 130.1%

FCF yield

—

TTM · current market cap

Buyback yield

—

P / FCF

—

P / operating cash flow

—

Earnings yield

-19.9%

Historical valuation

8 metrics

P / E historical average (3Y)

—

P / E historical average (5Y)

—

EV / revenue historical average (3Y)

3.7×

reciprocal yield 27.4%

EV / revenue historical average (5Y)

3.7×

reciprocal yield 27.4%

EV / EBIT historical average (3Y)

—

EV / EBIT historical average (5Y)

—

EV / EBITDA historical average (3Y)

—

EV / EBITDA historical average (5Y)

—

Dividends & buybacks

7 metrics

Dividend yield

—

Trailing 12 months

Payout ratio

—

Shareholder yield

—

Dividend / share (TTM)

—

Dividend growth YoY

—

Dividend growth streak

—

Last ex-dividend

—

Earnings calendar

2 metrics

Next earnings

—

Last earnings

2022-11-09

Profitability

9 metrics

Gross margin

—

Operating margin

-117.7%

Trailing 12 months

Net margin

-53.3%

Gross profit (TTM)

$2.90M

Operating profit (TTM)

−$22.62M

Net income (TTM)

−$10.23M

Trailing 12 months

Diluted EPS (TTM)

$-2.10

FCF margin

—

Effective tax rate

—

Per share

11 metrics

Revenue per diluted share (TTM)

—

Gross profit per diluted share (TTM)

—

Operating profit per diluted share (TTM)

—

EBITDA per diluted share (TTM)

—

Net income per diluted share (TTM)

—

Operating cash flow per diluted share (TTM)

—

Free cash flow per diluted share (TTM)

—

Capital expenditures per diluted share (TTM)

—

R&D per diluted share (TTM)

—

Stock compensation per diluted share (TTM)

—

Book value per share

$149.84

Growth

11 metrics

Revenue growth YoY

-82.8%

Year over year

Net income growth YoY

—

Revenue (TTM)

$19.21M

Trailing 12 months

EPS growth YoY

—

Shares change YoY

+90.1%

Year over year · more shares

Revenue CAGR (3Y)

+59.4%

Revenue CAGR (5Y)

—

EPS CAGR (3Y)

—

EPS CAGR (5Y)

—

FCF CAGR (3Y)

—

FCF CAGR (5Y)

—

Quality

14 metrics

Return on equity

-15.3%

Return on assets

-13.7%

Debt / equity

—

Current ratio

9.7

EBITDA (TTM)

−$37.12M

Free cash flow (TTM)

—

Quick ratio

—

Interest coverage

—

Net debt / EBITDA

—

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Cash & equivalents

$10.49M

Total assets

$74.97M

Total debt

—

Cash flow & spend

7 metrics

Operating cash flow (TTM)

−$13.31M

Capital expenditures (TTM)

$0

R&D (TTM)

$26.24M

SG&A (TTM)

$15.59M

Stock compensation (TTM)

$2.36M

R&D / revenue

136.6%

Stock compensation / revenue

12.3%

Ownership (13F)

3 metrics

13F filers

39

13F filer change QoQ

-7

Institutional ownership

51.7%

Short interest

3 metrics

Short interest

4.2%

Latest settlement · 3.1 days to cover

Days to cover

3.1d

Short-squeeze score

62 / 100

Insider activity

2 metrics

Net insider buying (90D)

—

Insider-sentiment score

—

Risk flags

1 metrics

Going concern

—

SCYX · Scynexis Inc

SCYX metrics

Market overview

Price action

Company

Valuation

Historical valuation

Dividends & buybacks

Earnings calendar

Profitability

Growth

Quality

Cash flow & spend

Ownership (13F)

Short interest

Insider activity

Risk flags

No metrics match that search